https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accretion-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/area-of-real-estate-property https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/decrease-in-utb-is-reasonably-possible https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/disposal-group-including-discontinued-operation-depreciation-and-amortization https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/government-contract-receivable-unbilled-amounts https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/increase-in-utb-is-reasonably-possible https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/loans-payable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/loans-payable-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/loans-payable-fair-value-disclosure https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/long-term-loans-payable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/new-claims-filed-number https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/prepaid-rent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-costs-and-asset-impairment-charges https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/shares-issued-value-issued-for-services https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/shares-issued-value-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/temporary-equity-value-excluding-additional-paid-in-capital https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/unbilled-contracts-receivable https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/tetraphase-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted